Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Anastrozole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 known ✓ | P11511 | 19/20 | 0.85 |
| ▸ | UGT1A4 | P22310 | 1/20 | 0.85 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.85 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | STS | P08842 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anastrozole SCHEMBL177942 | 0.92 | CYP19A1 (1.00) | CYP19A1UGT1A4PDE4DESR1STS | |
| Anastrozole SCHEMBL27927481 | 0.92 | CYP19A1 (1.00) | CYP19A1UGT1A4PDE4DESR1STS | |
| Anastrozole SCHEMBL9726 | 0.92 | CYP19A1 (1.00) | CYP19A1UGT1A4PDE4DESR1STS | |
| Anastrozole SCHEMBL6507726 | 0.92 | CYP19A1 (0.79) | CYP19A1UGT1A4PDE4DESR1STS | |
| Anastrozole SCHEMBL6507730 | 0.92 | CYP19A1 (0.79) | CYP19A1UGT1A4PDE4DESR1STS | |
| Anastrozole SCHEMBL5917785 | 0.91 | CYP19A1 (0.97) | CYP19A1UGT1A4PDE4DESR1STS | |
| Anastrozole SCHEMBL28771766 | 0.91 | CYP19A1 (0.97) | CYP19A1UGT1A4PDE4DESR1STS | |
| Anastrozole SCHEMBL3172308 | 0.91 | CYP19A1 (0.97) | CYP19A1UGT1A4PDE4DESR1STS | |
| SCHEMBL8069584 | 0.89 | CYP19A1 (0.79) | CYP19A1UGT1A4PDE4DESR1STS | |
| Anastrozole SCHEMBL4727358 | 0.89 | CYP19A1 (0.83) | CYP19A1UGT1A4PDE4DESR1STS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436029-B2 | Pharmaceutical forms, and methods of making and using the same | TRANSFORM PHARMACEUTICALS, INC. (US) | 2013-05-07 | — | — | US | claimed |
| US-20120015993-A1 | Novel Pharmaceutical Forms, and Methods of Making and Using the Same | UNIVERSITY OF SOUTH FLORIDA (US) | 2012-01-19 | — | — | US | claimed |
| WO-2005089511-A2 | NOVEL PHARMACEUTICAL FORMS, AND METHODS OF MAKING AND USING THE SAME | TRANSFORM PHARMACEUTICALS, INC. (US) | 2005-09-29 | — | — | WO | claimed |
| CN-103450099-A | Anastrozole and new crystal form of monohydrate thereof, preparation and application | HANGZHOU HUADONG MEDICINE GROUP BIOLOGY ENG RES CO LTD | 2013-12-18 | — | — | CN | disclosed |
| US-20130289280-A1 | NOVEL PHARMACEUTICAL FORMS, AND METHODS OF MAKING AND USING THE SAME | TRANSFORM PHARMACEUTICALS, INC. (US) | 2013-10-31 | — | — | US | disclosed |
| US-8436029-B2 | Pharmaceutical forms, and methods of making and using the same | TRANSFORM PHARMACEUTICALS, INC. (US) | 2013-05-07 | — | — | US | disclosed |
| US-20120015993-A1 | Novel Pharmaceutical Forms, and Methods of Making and Using the Same | UNIVERSITY OF SOUTH FLORIDA (US) | 2012-01-19 | — | — | US | disclosed |
| WO-2005105762-A1 | IMPROVED PROCESS FOR THE PREPARATION OF HIGH PURITY ANASTROZOLE | NATCO PHARMA LIMITED (IN) | 2005-11-10 | — | — | WO | disclosed |
| WO-2005089511-A2 | NOVEL PHARMACEUTICAL FORMS, AND METHODS OF MAKING AND USING THE SAME | TRANSFORM PHARMACEUTICALS, INC. (US) | 2005-09-29 | — | — | WO | disclosed |